|
Index of reports
> Cases with Thrombocytopenia (10)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Thalomid (Thalidomide) where reactions include thrombocytopenia. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Thalomid side effects in
Reported by a individual with unspecified qualification from Spain on 2012-07-30
Patient:
Reactions: Colon Cancer, Pulmonary Embolism, Toxicity To Various Agents, Multiple Myeloma, Herpes Zoster, Death, Neuropathy Peripheral, Gastrointestinal Disorder, Neutropenia, Thrombocytopenia, Deep Vein Thrombosis, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bortezomib
Dosage: 1.3mg/m2 on days 1,4,8 and 11 q 3 weeks
Indication: Multiple Myeloma
Thalomid
Dosage: 200mg daily (escalating doses in the first cycle)
Administration route: Oral
Indication: Multiple Myeloma
Dexamethasone
Dosage: 40mg on days 1-4 and 9-12 at 4-week intervals
Administration route: Oral
Indication: Multiple Myeloma
Possible Thalomid side effects in
Reported by a individual with unspecified qualification from United States on 2012-06-06
Patient:
Reactions: Lymphopenia, Multiple Myeloma, Constipation, Somnolence, Peripheral Sensory Neuropathy, Myopathy, Fatigue, Malaise, Embolism, Neutropenia, Thrombocytopenia, Blood Creatinine Increased, Lethargy
Drug(s) suspected as cause:
Thalomid
Administration route: Oral
Indication: Multiple Myeloma
Cyclophosphamide
Indication: Multiple Myeloma
Dexamethasone
Indication: Multiple Myeloma
Carfilzomib
Indication: Multiple Myeloma
Carfilzomib
Dosage: 20/45 mg/m3
Other drugs received by patient: Herpes Zoster Prophylaxis; Aspirin
Possible Thalomid side effects in
Reported by a health professional (non-physician/pharmacist) from Korea, Republic of on 2012-05-08
Patient:
Reactions: Neuropathy Peripheral, Pneumonia, Diabetes Mellitus, Sepsis, Anaemia, Neutropenia, Thrombocytopenia, Disease Progression, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Dexamethasone
Indication: Multiple Myeloma
Thalomid
Dosage: 100 milligram
Administration route: Oral
Indication: Multiple Myeloma
Bortezomib
Indication: Multiple Myeloma
Bortezomib
Vincristine
Indication: Multiple Myeloma
Adriamycin PFS
Indication: Multiple Myeloma
Other drugs received by patient: Aspirin; Neupogen; Melphalan Hydrochloride
Possible Thalomid side effects in male
Reported by a physician from United States on 2012-04-27
Patient: male, weighing 158.9 kg (349.6 pounds)
Reactions: White Blood Cell Count Decreased, Basal Cell Carcinoma, Febrile Neutropenia, Squamous Cell Carcinoma of Skin, Thrombocytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Revlimid
Administration route: Oral
Start date: 2011-11-01
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2008-01-01
End date: 2008-07-18
Melphalan Hydrochloride
Start date: 2006-01-01
End date: 2007-01-01
Melphalan Hydrochloride
Dosage: 2 milligram
Start date: 2011-04-08
Melphalan Hydrochloride
End date: 2011-11-21
Thalomid
Dosage: dose increased
Start date: 2006-01-01
End date: 2007-01-01
Thalomid
Indication: Multiple Myeloma
Start date: 2004-01-01
End date: 2005-01-01
Revlimid
Dosage: 15 milligram
Administration route: Oral
Start date: 2011-04-08
End date: 2012-01-12
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2011-07-01
Revlimid
Administration route: Oral
Start date: 2008-07-18
Thalomid
Start date: 2007-01-01
End date: 2008-01-01
Other drugs received by patient: Metoclopramide; Clopidogrel; Lovastatin; Zometa; Rocephin; Filgrastim; Lisinopril and Hydrochlorothiazide; Atenolol; Zolpidem; Mupirocin; Neupogen; Warfarin Sodium; Plavix; Hydrocodone Bitartrate + Acetaminophen; Aspirin; Neupogen; Prednisone TAB; Solu-Medrol; Sodium Chloride; Kenalog
Possible Thalomid side effects in male
Reported by a pharmacist from United States on 2012-04-20
Patient: male, weighing 72.6 kg (159.8 pounds)
Reactions: Thrombocytopenia, Cerebral Haemorrhage
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Thalomid
Administration route: Oral
Start date: 2011-11-01
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2010-10-01
End date: 2011-01-01
Revlimid
Dosage: 2.5 milligram
Administration route: Oral
Start date: 2012-02-23
Thalomid
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-10-01
Thalomid
Administration route: Oral
Start date: 2011-12-01
Revlimid
Dosage: 15 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-04-01
End date: 2010-01-01
Other drugs received by patient: Treanda; Decadron; Allopurinol; Omeprazole; Carvedilol
Possible Thalomid side effects in male
Reported by a physician from United States on 2012-04-03
Patient: male, weighing 158.9 kg (349.6 pounds)
Reactions: White Blood Cell Count Decreased, Basal Cell Carcinoma, Squamous Cell Carcinoma of Skin, Thrombocytopenia
Drug(s) suspected as cause:
Revlimid
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-11-01
End date: 2012-01-01
Melphalan Hydrochloride
Dosage: 2 milligram
Start date: 2011-04-08
Revlimid
Dosage: 10 milligram
Administration route: Oral
Start date: 2011-07-01
Thalomid
Indication: Multiple Myeloma
Start date: 2004-01-01
End date: 2005-01-01
Thalomid
Dosage: dose increased
Start date: 2006-01-01
End date: 2007-01-01
Thalomid
Start date: 2007-01-01
End date: 2008-01-01
Melphalan Hydrochloride
End date: 2011-11-21
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2008-01-01
Revlimid
Dosage: 15 milligram
Administration route: Oral
Start date: 2011-04-08
Melphalan Hydrochloride
Start date: 2006-01-01
End date: 2007-01-01
Other drugs received by patient: Filgrastim; Lovastatin; Metoclopramide; Zometa; Rocephin; Atenolol; Aspirin; Prednisone TAB; Solu-Medrol; Lisinopril and Hydrochlorothiazide; Neupogen; Clopidogrel; Zolpidem; Hydrocodone Bitartrate and Acetaminophen; Warfarin Sodium; Sodium Chloride; Mupirocin; Neupogen; Kenalog
Possible Thalomid side effects in
Reported by a individual with unspecified qualification from United States on 2012-03-13
Patient:
Reactions: Pneumonia Aspiration, Hyperglycaemia, Anaemia, Muscular Weakness, Rash, Constipation, Hypercalcaemia, Disease Progression, Fatigue, Neuropathy Peripheral, Oedema Peripheral, Neutropenia, Thrombocytopenia, Asthenia, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Thalomid
Dosage: 200 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2009-11-01
End date: 2011-01-01
Revlimid
Dosage: 50 milligram
Administration route: Oral
End date: 2011-01-01
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2009-11-01
Other drugs received by patient: Dexamethasone; Aspirin; Bisphosphonates; Neupogen; Blood Product Support; Warfarin Sodium; Heparin
Possible Thalomid side effects in 65 year old
Reported by a individual with unspecified qualification from United States on 2012-03-05
Patient: 65 year old
Reactions: Renal Failure, Tumour Lysis Syndrome, Respiratory Failure, Disseminated Intravascular Coagulation, Anaemia, Lung Infiltration, Thrombocytopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Dexamethasone
Dosage: 40 milligram
Indication: Natural Killer-Cell Lymphoblastic Lymphoma
Start date: 2009-11-02
Bortezomib
Dosage: 1 milligram/sq. meter
Indication: Natural Killer-Cell Lymphoblastic Lymphoma
Start date: 2009-11-02
Thalomid
Dosage: 50 milligram
Administration route: Oral
Indication: Natural Killer-Cell Lymphoblastic Lymphoma
Start date: 2009-11-02
Possible Thalomid side effects in
Reported by a individual with unspecified qualification from United States on 2012-03-05
Patient:
Reactions: Weight Decreased, Gastrointestinal Haemorrhage, Myocardial Ischaemia, Peripheral Sensory Neuropathy, Sedation, Hypoxia, Pneumonitis, Anaemia, Hypotension, Tremor, Exfoliative Rash, Depressed Level of Consciousness, Neutropenia, Hypersensitivity, Radiation Skin Injury, Constipation, Hypokalaemia, Neutropenic Infection, Fatigue, Ileus, Bone Marrow Failure, Dizziness, Oedema, Thrombocytopenia, Peripheral Motor Neuropathy, Decreased Appetite, Dyspnoea, Vomiting, Febrile Neutropenia, Embolism, Hypertension, Radiation Dysphagia, Leukopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Paclitaxel
Dosage: 45 milligram/sq. meter
Thalomid
Dosage: 200-1000 mg
Administration route: Oral
Carboplatin
Dosage: auc=2
Carboplatin
Dosage: auc=6
Paclitaxel
Dosage: 225 milligram/sq. meter
Other drugs received by patient: Aspirin
Possible Thalomid side effects in female
Reported by a physician from United States on 2011-11-08
Patient: female
Reactions: Throat Irritation, Thrombocytopenia, Throat Tightness
Drug(s) suspected as cause:
Thalomid
Other drugs received by patient: Prednisone; Lipitor; Prednisone; Prednisone; Prednisone
|
